Skip to content

4Accepted Sep 3, 6:41 PM ET

BioMarin (BMRN) EVP George E. Davis Sells 17,557 Shares

BMRNBIOMARIN PHARMACEUTICAL INC

Accepted (ET)

6:41 PM

Sep 3, 2026

Filed

Sep 3, 2026

Documents

1

Size

5.0 KB

Summary

BioMarin (BMRN) EVP George E. Davis Sells 17,557 Shares

Updated

What Happened

  • George E. Davis, EVP and Chief Legal Officer of BioMarin Pharmaceutical Inc. (BMRN), sold 17,557 shares in an open-market disposition on September 2, 2026.
  • The filing reports a weighted average sale price of $66.28 per share, for total proceeds of approximately $1,163,748.

Key Details

  • Transaction date: 2026-09-02 (reported on Form 4 filed 2026-09-03).
  • Price: weighted average $66.28; actual sale prices ranged from $66.271 to $66.39 (see footnote).
  • Shares owned after transaction: not disclosed in the provided excerpt of the filing.
  • Transaction code: S (sale); no 10b5-1 plan, tax withholding or other special footnotes indicated beyond the price range disclosure.
  • Filing timeliness: Reported the next day (appears timely, not flagged as late).

Context

  • This was an open-market sale. Sales by insiders are common and can be for many personal reasons; they do not by themselves indicate the insider’s view of company prospects. Purchases tend to be more informative about insider conviction.

AI-written summary · check the filing